Clinical Trial Update: A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study comparing relative bioavailability and food effects of GSK3640254 tablet and capsule in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• GSK3640254

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2021-03-03